Want to see KR:003000 full AI Analyst Report?
Bukwang Pharmaceutical Co., Ltd. (003000) Financial Statements
Bukwang Pharmaceutical Co., Ltd. Financial Overview
Bukwang Pharmaceutical Co., Ltd.'s market cap is currently $362.10B. The company's EPS TTM is $60.36; its P/E ratio is 63.51; and it has a dividend yield of 3.41%. Bukwang Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 200.71B | $ 160.09B | $ 125.93B | $ 190.91B | $ 182.49B |
| Gross Profit | $ 95.72B | $ 74.34B | $ 50.05B | $ 79.43B | $ 75.76B |
| Operating Income | $ 14.16B | $ 1.62B | $ -37.50B | $ -230.64M | $ 5.62B |
| EBITDA | $ 19.65B | $ 7.63B | $ -31.47B | $ 4.89B | $ 11.40B |
| Net Income | $ 12.57B | $ -2.64B | $ -31.33B | $ -2.47B | $ -916.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 216.21B | $ 130.09B | $ 151.23B | $ 85.52B | $ 84.28B |
| Total Assets | $ 502.17B | $ 373.18B | $ 429.02B | $ 400.93B | $ 397.42B |
| Total Debt | $ 80.34B | $ 79.42B | $ 79.39B | $ 930.79M | $ 1.56B |
| Net Debt | $ 41.13B | $ -10.67B | $ -71.84B | $ -84.59B | $ -81.22B |
| Total Liabilities | $ 161.24B | $ 129.03B | $ 194.75B | $ 129.08B | $ 117.36B |
| Stockholders' Equity | $ 341.46B | $ 243.68B | $ 226.31B | $ 263.22B | $ 269.61B |
| Cash Flow | |||||
| Free Cash Flow | $ 11.15B | $ 31.75B | $ -13.32B | $ 11.47B | $ 25.74B |
| Operating Cash Flow | $ 18.48B | $ 34.36B | $ -9.36B | $ 16.46B | $ 26.52B |
| Investing Cash Flow | $ -95.68B | $ -27.73B | $ -2.32B | $ -3.15B | $ 4.75B |
| Financing Cash Flow | $ 82.76B | $ -67.65B | $ 76.84B | $ -10.40B | $ -27.48B |
Currency in KRW